Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
14.05
+0.17 (1.22%)
At close: Mar 6, 2026, 4:00 PM EST
14.21
+0.16 (1.14%)
After-hours: Mar 6, 2026, 6:59 PM EST
Jade Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Selling, General & Admin | 20.42 | 8.61 |
| Research & Development | 93.12 | 55.87 |
| Operating Expenses | 113.54 | 64.48 |
| Operating Income | -113.54 | -64.48 |
| Interest & Investment Income | 7.78 | 2.32 |
| Other Non Operating Income (Expenses) | -0.01 | -25.2 |
| EBT Excluding Unusual Items | -105.77 | -87.36 |
| Other Unusual Items | -21.58 | -6.6 |
| Pretax Income | -127.35 | -93.96 |
| Income Tax Expense | 0.06 | - |
| Net Income | -127.41 | -93.96 |
| Preferred Dividends & Other Adjustments | -27.27 | - |
| Net Income to Common | -100.14 | -93.96 |
| Shares Outstanding (Basic) | 31 | 5 |
| Shares Outstanding (Diluted) | 31 | 5 |
| Shares Change (YoY) | 527.20% | - |
| EPS (Basic) | -3.19 | -18.79 |
| EPS (Diluted) | -3.19 | -18.79 |
| EBITDA | -113.52 | - |
| D&A For EBITDA | 0.02 | - |
| EBIT | -113.54 | -64.48 |
Source: S&P Capital IQ. Standard template.
Financial Sources.